tetrahydropalmatine has been researched along with Acute Kidney Failure in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, D; Jiang, H; Li, C; Li, L; Tan, F; Wang, W; Yi, Y; Yuan, J; Zeng, S; Zhou, H | 1 |
1 other study(ies) available for tetrahydropalmatine and Acute Kidney Failure
| Article | Year |
|---|---|
L-tetrahydropalmatine attenuates cisplatin-induced nephrotoxicity via selective inhibition of organic cation transporter 2 without impairing its antitumor efficacy.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Berberine Alkaloids; Cells, Cultured; Cisplatin; Dogs; Kidney Tubules; Madin Darby Canine Kidney Cells; Male; Mice, Inbred ICR; Mice, Nude; Organic Cation Transport Proteins; Organic Cation Transporter 2; Protective Agents; Xenograft Model Antitumor Assays | 2020 |